Work

Treatment Outcomes of Patients With Tardive Dyskinesia and Chronic Schizophrenia

Year: 2020

Type: article

Abstract: We compared the response to antipsychotic treatment between patients with and without tardive dyskinesia (TD) and examined the course of TD.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/wks2-yf62

Authors: Lieberman, Jeffrey A., Davis, Vicki G., Swartz, Marvin S., Chakos, Miranda H., Keefe, Richard S.E., McEvoy, Joseph P., Campbell, E. Cabrina, Caroff, Stanley N., Rosenheck, Robert A., Riggio, Silvana, Saltz, Bruce L., Davis, Sonia M., Miller, Del D., Stroup, T. Scott

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Veterans Affairs, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Yale University, University of Southern California, University of Rochester, H. Lundbeck A/S, Eli Lilly Canada, Medical Research Council, National Medical Research Council, National Institute of Mental Health

Awards: G1519962528, G8700482840

OpenAlex ID: W4301260122

FWCI:

Cites:

Cited by: 1

Related to: 10